MedPath

A skin irritation study of BBI-4000 in healthy adult males (phase 1)

Not Applicable
Conditions
hyperhidrosis
Registration Number
JPRN-UMIN000020546
Lead Sponsor
Kaken Pharmaceutical Co., LTD
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
28
Inclusion Criteria

Not provided

Exclusion Criteria

1. Has a history of glaucoma or enlarged prostate 2. Has a wound, scar, birthmark, or tattoo on the back (paraspinal sites) 3. Complicated with liver, kidney, or heart diseases or hematological disorders or history thereof 4. Has a history of allergic reactions to medications or specific constitutions (e.g. alcohol hypersensitivity) 5. Regularly uses drugs 6. Has a history of drug abuse (narcotics/stimulants/psychotropics) or alcohol dependence

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Skin irritability at 48 hours and 72 hours after administraion
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath